Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 1/2010

01.02.2010 | Research Article

Electronic screening of medical records to detect inpatients at risk of drug-related problems

verfasst von: Isabelle Roten, Stefan Marty, Johnny Beney

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective The objective of the study is to develop and validate a screening tool for clinical pharmacists (CPs), comprising electronic queries (EQs) structured to identify inpatients at risk of drug-related problems (DRPs) [1]. Setting Internal Medicine and Geriatric Units of the (multi-site) Hôpital du Valais. Method EQs, identifying patients with potential DRPs and/or those requiring a medication review were compared with a CP-conducted manual check of all electronic medical records (EMRs), during their standard activities. The queries were aimed at identifying patients receiving drugs such as cytochrome P450 inducers, inhibitors or high-risk medications, those with renal impairment, those on digoxin with low serum potassium, those with intravenous (i.v.) anti-infectives or i.v. acetaminophen for more than 3 days, and elderly patients with polymedication (≥80 years and >10 drugs). Main outcome measure Sensitivity and specificity of the screening tool. Results Five hundred and one patients seen by 4 CPs during 36 ward rounds were screened. The EQs identified 64.7% of the visited inpatients. The CPs detected at least one DRP in 64.9% of all patients. A sensitivity of 85.1% and a specificity of 60.4% were achieved. Conclusion This tool allows for efficient and rapid screening of patients at risk of DRPs in preparation for the ward round. It helps CPs to prioritize their medication reviews and to optimize their workload.
Literatur
2.
Zurück zum Zitat Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Drug-related problems in hospitals—a review of the recent literature. Drug Saf. 2007;30:379–407.CrossRefPubMed Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Drug-related problems in hospitals—a review of the recent literature. Drug Saf. 2007;30:379–407.CrossRefPubMed
3.
Zurück zum Zitat Spinewine A, Dhillon S, Mallet L, Tulkens PM, Wilmotte L, Swine C. Implementation of ward-based clinical pharmacy services in Belgium—description of the impact on a geriatric unit. Ann Pharmacother. 2006;40(4):720–8.CrossRefPubMed Spinewine A, Dhillon S, Mallet L, Tulkens PM, Wilmotte L, Swine C. Implementation of ward-based clinical pharmacy services in Belgium—description of the impact on a geriatric unit. Ann Pharmacother. 2006;40(4):720–8.CrossRefPubMed
4.
Zurück zum Zitat Eviter les effets indésirables par interactions médicamenteuses. Prescrire, Le Guide 2008. 2007;27(290):1–208. Eviter les effets indésirables par interactions médicamenteuses. Prescrire, Le Guide 2008. 2007;27(290):1–208.
5.
Zurück zum Zitat Murphy JE, Malone DC, Olson BM, Grizzle AJ, Armstrong EP, Skrepnek GH. Development of computerized alerts with management strategies for 25 serious drug–drug interactions. Am J Health Syst Pharm. 2009;66(1):38–44.CrossRefPubMed Murphy JE, Malone DC, Olson BM, Grizzle AJ, Armstrong EP, Skrepnek GH. Development of computerized alerts with management strategies for 25 serious drug–drug interactions. Am J Health Syst Pharm. 2009;66(1):38–44.CrossRefPubMed
6.
Zurück zum Zitat Harris W. Methotrexate-associated medication errors. Am J Health Syst Pharm. 2004;61(24):2635.PubMed Harris W. Methotrexate-associated medication errors. Am J Health Syst Pharm. 2004;61(24):2635.PubMed
7.
Zurück zum Zitat Moore TJ, Walsh CS, Cohen MR. Reported medication errors associated with methotrexate. Am J Health Syst Pharm. 2004;61(13):1380–4.PubMed Moore TJ, Walsh CS, Cohen MR. Reported medication errors associated with methotrexate. Am J Health Syst Pharm. 2004;61(13):1380–4.PubMed
8.
Zurück zum Zitat Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.CrossRefPubMed Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.CrossRefPubMed
9.
Zurück zum Zitat K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39(2 Suppl 1):S1–S266. K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39(2 Suppl 1):S1–S266.
10.
Zurück zum Zitat van Dijk EA, Drabbe NR, Kruijtbosch M, De Smet PA. Drug dosage adjustments according to renal function at hospital discharge. Ann Pharmacother. 2006;40(7–8):1254–60.PubMed van Dijk EA, Drabbe NR, Kruijtbosch M, De Smet PA. Drug dosage adjustments according to renal function at hospital discharge. Ann Pharmacother. 2006;40(7–8):1254–60.PubMed
11.
Zurück zum Zitat Wong NA, Jones HW. An analysis of discharge drug prescribing amongst elderly patients with renal impairment. Postgrad Med J. 1998;74(873):420–2.CrossRefPubMed Wong NA, Jones HW. An analysis of discharge drug prescribing amongst elderly patients with renal impairment. Postgrad Med J. 1998;74(873):420–2.CrossRefPubMed
12.
Zurück zum Zitat Salomon L, Deray G, Jaudon MC, Chebassier C, Bossi P, Launay-Vacher V, et al. Medication misuse in hospitalized patients with renal impairment. Int J Qual Health Care. 2003;15(4):331–5.CrossRefPubMed Salomon L, Deray G, Jaudon MC, Chebassier C, Bossi P, Launay-Vacher V, et al. Medication misuse in hospitalized patients with renal impairment. Int J Qual Health Care. 2003;15(4):331–5.CrossRefPubMed
13.
Zurück zum Zitat Mordasini MR, Krähenbühl S, Schlienger RG. Appropriateness of digoxin level monitoring. Swiss Med Wkly. 2002;132(35–36):506–12.PubMed Mordasini MR, Krähenbühl S, Schlienger RG. Appropriateness of digoxin level monitoring. Swiss Med Wkly. 2002;132(35–36):506–12.PubMed
14.
Zurück zum Zitat Aronson JK, Hardman M. ABC of monitoring drug therapy. Digoxin. BMJ. 1992;305(6862):1149–52.CrossRefPubMed Aronson JK, Hardman M. ABC of monitoring drug therapy. Digoxin. BMJ. 1992;305(6862):1149–52.CrossRefPubMed
15.
Zurück zum Zitat von Gunten V, Amos V, Sidler AL, Beney J, Troillet N, Reymond JP. Hospital pharmacists’ reinforcement of guidelines for switching from parenteral to oral antibiotics: a pilot study. Pharm World Sci. 2003;25(2):52–5.CrossRef von Gunten V, Amos V, Sidler AL, Beney J, Troillet N, Reymond JP. Hospital pharmacists’ reinforcement of guidelines for switching from parenteral to oral antibiotics: a pilot study. Pharm World Sci. 2003;25(2):52–5.CrossRef
16.
Zurück zum Zitat Bensimon E, Marty S, Theytaz C, Frasseren M, Eckert P, Beney J. Réduction des coûts du paracétamol dans une unité de soins intensifs [Poster]. Quatorzièmes journées franco-suisses de pharmacie hospitalière, Lausanne, 2007. Bensimon E, Marty S, Theytaz C, Frasseren M, Eckert P, Beney J. Réduction des coûts du paracétamol dans une unité de soins intensifs [Poster]. Quatorzièmes journées franco-suisses de pharmacie hospitalière, Lausanne, 2007.
17.
Zurück zum Zitat Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care. 2003;12(3):176–80.CrossRefPubMed Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care. 2003;12(3):176–80.CrossRefPubMed
18.
Zurück zum Zitat Hanlon JT, Artz MB, Pieper CF, Lindblad CI, Sloane RJ, Ruby CM, et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother. 2004;38(1):9–14.CrossRefPubMed Hanlon JT, Artz MB, Pieper CF, Lindblad CI, Sloane RJ, Ruby CM, et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother. 2004;38(1):9–14.CrossRefPubMed
19.
Zurück zum Zitat Jones SR, Carley S, Harrison M. An introduction to power and sample size estimation. Emerg Med J. 2003;20(5):453–8.CrossRefPubMed Jones SR, Carley S, Harrison M. An introduction to power and sample size estimation. Emerg Med J. 2003;20(5):453–8.CrossRefPubMed
20.
Zurück zum Zitat Buderer NM. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med. 1996;3(9):895–900.CrossRefPubMed Buderer NM. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med. 1996;3(9):895–900.CrossRefPubMed
21.
Zurück zum Zitat Bindoff IK, Tenni PC, Peterson GM, Kang BH, Jackson SL. Development of an intelligent decision support system for medication review. J Clin Pharm Ther. 2007;32(1):81–8.CrossRefPubMed Bindoff IK, Tenni PC, Peterson GM, Kang BH, Jackson SL. Development of an intelligent decision support system for medication review. J Clin Pharm Ther. 2007;32(1):81–8.CrossRefPubMed
Metadaten
Titel
Electronic screening of medical records to detect inpatients at risk of drug-related problems
verfasst von
Isabelle Roten
Stefan Marty
Johnny Beney
Publikationsdatum
01.02.2010
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 1/2010
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-009-9352-6

Weitere Artikel der Ausgabe 1/2010

International Journal of Clinical Pharmacy 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.